Author:
Hornstrup Bodil G.,Hoffmann-Petersen Nikolai,Lauridsen Thomas Guldager,Bech Jesper N.
Abstract
Abstract
Purpose
Patients with treatment resistant hypertension (TRH) are at particular risk of cardiovascular disease. Life style modification, including sodium restriction, is an important part of the treatment of these patients. We aimed to analyse if self-performed dietary sodium restriction could be implemented in patients with TRH and to evaluate the effect of this intervention on blood pressure (BP). Moreover, we aimed to examine if mechanisms involving nitric oxide, body water content and BNP, renal function and handling of sodium were involved in the effect on nocturnal and 24-h BP. Also, measurement of erythrocyte sodium sensitivity was included as a possible predictor for the effect of sodium restriction on BP levels.
Patients and methods
TRH patients were included for this interventional four week study: two weeks on usual diet and two weeks on self-performed sodium restricted diet with supplementary handed out sodium-free bread. At the end of each period, 24-h BP and 24-h urine collections (sodium, potassium, ENaC) were performed, blood samples (BNP, NOx, salt blood test) were drawn, and bio impedance measurements were made.
Results
Fifteen patients, 11 males, with a mean age of 59 years were included. After sodium restriction, urinary sodium excretion decreased from 186 (70) to 91 [51] mmol/24-h, and all but one reduced sodium excretion. Nocturnal and 24-h systolic BP were significantly reduced (− 8 and − 10 mmHg, respectively, p < 0.05). NOx increased, BNP and extracellular water content decreased, all significantly. Change in NOx correlated to the change in 24-h systolic BP. BP response after sodium restriction was not related to sodium sensitivity examined by salt blood test.
Conclusion
Self-performed dietary sodium restriction was feasible in a population of patients with TRH, and BP was significantly reduced. Increased NOx synthesis may be involved in the BP lowering effect of sodium restriction.
Trial registration
The study was registered in Clinical trials with ID: NCT06022133.
Funder
Gødstrup Hospital’s Research Foundation
Hjerteforeningen
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Lawes CMM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet (London, England). 2008;371(9623):1513–8.
2. Collaborators G. 2017 RF. Global, regional, and national comparative risk assessment of 84 behaviournvironmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England) [Internet]. 2018 Nov 10 [cited 2021 Sep 28];392(10159):1923. Available from: /pmc/articles/PMC6227755/.
3. Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for themanagement of arterial hypertension. European Heart Journal. Volume 39. Oxford University Press; 2018. pp. 3021–104.
4. Braam B, Taler SJ, Rahman M, Fillaus JA, Greco BA, Forman JP, et al. Recognition and Management of resistant hypertension. Clin J Am Soc Nephrol. 2017;12(3):524–35.
5. Kannel WB. Elevated systolic blood pressure as a cardiovascular risk factor. American Journal of Cardiology. Volume 85. Elsevier Inc.; 2000. pp. 251–5.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献